Alibaba Health Informatio... (ALBBY)

AI Score

Unlock

12.18

0.67 (5.82%)

At close: Apr 25, 2025, 2:43 PM

Alibaba Health Information Technology Income Statement

Financials in CNY. Fiscal year is April - March.

Fiscal Year	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Mar 31, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 31, 2022	Sep 30, 2021	Mar 31, 2021	Sep 30, 2020	Mar 31, 2020	Sep 30, 2019	Mar 31, 2019	Sep 30, 2018	Mar 31, 2018	Sep 30, 2017	Mar 31, 2017	Sep 30, 2016
Revenue	42.29B	39.72B	37.98B	32.08B	28.93B	24.88B	21B	16.76B	12.81B	9.21B	6.65B	4.32B	2.86B	1.36B	514.48M	111.62M
Cost of Revenue	32.99B	31.15B	30.04B	25.67B	23.07B	19.39B	16.19B	12.68B	9.79B	6.85B	4.92B	3.14B	2.07B	922.13M	297.9M	26.1M
Gross Profit	9.3B	8.57B	7.94B	6.41B	5.87B	5.49B	4.81B	4.08B	3.03B	2.36B	1.73B	1.18B	790.17M	442.67M	216.57M	85.52M
Operating Income	625.24M	208.57M	-558.83M	-1.14B	-1.28B	-553.63M	-21.49M	154.69M	-101.41M	-106.64M	-139.61M	-204.34M	-236.38M	-301.13M	-305.86M	-322.41M
Interest Income	679.17M	527.61M	446.05M	352.9M	311.73M	253.8M	203.32M	104.15M	57.88M	32.08M	33.11M	17.89M	5.94M	5.96M	11.64M	18.36M
Pretax Income	1.32B	1.03B	528.34M	-78.54M	-175.74M	171.36M	404.69M	333.54M	27.06M	-55.2M	-64.4M	-173.94M	-197.47M	-298.67M	-301.25M	-301.89M
Net Income	1.26B	981.54M	501.87M	-103.36M	-200.4M	116.82M	343.1M	276.85M	-4.43M	-83.05M	-98.01M	-191.08M	-212.2M	-298.54M	-298.75M	-294.01M
Selling & General & Admin	7.6B	7.34B	7.39B	6.48B	6.21B	5.27B	4.27B	3.44B	2.76B	2.11B	1.58B	1.15B	835.33M	566.78M	364.72M	274.51M
Research & Development	1.06B	997.14M	1.08B	1.05B	923.01M	746.38M	541.34M	482.29M	368.18M	354.16M	283.86M	229.9M	184.36M	169.96M	148.41M	126.59M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	8.44B	8.07B	7.86B	6.84B	6.36B	5.57B	4.61B	3.85B	3.02B	2.41B	1.79B	1.37B	993.58M	747.3M	529.46M	405.78M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	2.69B	2.64B	2.77B	2.84B	2.69B	2.21B	1.61B	1.23B	1.02B	788.09M	569.46M	357.94M	264.62M	199.56M	141.99M	130.35M
Cost & Expenses	41.44B	39.21B	37.9B	32.51B	29.42B	24.96B	20.8B	16.52B	12.81B	9.26B	6.71B	4.51B	3.07B	1.67B	827.37M	431.88M
Income Tax Expense	60.28M	50.61M	26.21M	23.89M	26.08M	60.24M	70.07M	70.68M	44.54M	44.19M	44.22M	25.07M	14.39M	2.16M	2.57M	2.9M
Shares Outstanding (Basic)	731.41M	677.65M	677.14M	675.86M	674.33M	673.75M	672.69M	656.09M	552.82M	551M	585.6M	522.45M	494.55M	424.38M	409.19M	408.74M
Shares Outstanding (Diluted)	731.47M	677.6M	678.1M	676.05M	674.37M	673.9M	676.59M	656.06M	601.34M	591.8M	583.07M	522.42M	494.46M	424.36M	409.17M	408.73M
EPS (Basic)	1.81	1.45	0.74	-0.15	-0.3	0.18	0.52	0.42	-0.01	-0.16	-0.19	-0.41	-0.5	-0.72	-0.73	-0.72
EPS (Diluted)	1.81	1.45	0.74	-0.15	-0.3	0.18	0.52	0.42	-0.01	-0.16	-0.19	-0.41	-0.5	-0.72	-0.73	-0.72
EBITDA	660.66M	247.72M	-515.44M	-1.1B	-1.25B	-533.45M	4.15M	174.73M	-86.08M	-99.22M	-133.09M	-196.78M	-229.44M	-294.52M	-299.45M	-316.68M
EBIT	623.97M	208.57M	-558.83M	-1.14B	-1.28B	-553.63M	-21.49M	154.69M	-101.41M	-106.64M	-139.61M	-204.34M	-236.38M	-301.13M	-305.86M	-322.41M
Depreciation & Amortization	36.69M	39.15M	43.39M	36.11M	30.9M	20.19M	25.64M	20.04M	15.33M	7.41M	6.51M	7.56M	6.95M	6.6M	6.41M	5.73M